Evidence map›Paper›PMID 30867315›Full record

ArticleJournal of virology2019

Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice.

Jessica Katy Skelton, Ana Maria Ortega-Prieto, Steve Kaye, Jose Manuel Jimenez-Guardeño, Jane Turner, Michael H Malim, Greg J Towers, Marcus Dorner

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jessica Katy SkeltonSection of Virology, Department of Medicine, Imperial College London, London, United Kingdom.
Ana Maria Ortega-PrietoSection of Virology, Department of Medicine, Imperial College London, London, United Kingdom a.ortega-prieto@imperial.ac.uk.
Steve KayeMolecular Diagnostics Unit, Imperial College London, London, United Kingdom.
Jose Manuel Jimenez-GuardeñoDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
Jane TurnerDivision of Infection and Immunity, University College London, London, United Kingdom.
Michael H MalimDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
Greg J TowersDivision of Infection and Immunity, University College London, London, United Kingdom.
Marcus DornerSection of Virology, Department of Medicine, Imperial College London, London, United Kingdom.ORCID 0000-0003-0321-4226
Imperial College London · GBKing's College London · GBUniversity College London · GB

Funding

Department of HealthWellcome Trust 090940Wellcome Trust 104771/Z/14/ZWellcome Trust 106223/Z/14/Z
6 · The paper itself

Abstract

Human immunodeficiency virus type 1 (HIV-1) infection is associated with aberrant immune activation; however, most model systems for HIV-1 have been used during established infection. Here, we utilize ultrasensitive HIV-1 quantification to delineate early events during the eclipse, burst, and chronic phases of HIV-1 infection in humanized mice. We show that very early in infection, HIV-1 suppresses peripheral type I interferon (IFN) and interferon-stimulated gene (ISG) responses, including the HIV-1 restriction factor IFI44. At the peak of innate immune activation, prior to CD4 T cell loss, HIV-1 infection differentially affects peripheral and lymphoid Toll-like receptor (TLR) expression profiles in T cells and macrophages. This results in a trend toward an altered activation of nuclear factor κB (NF-κB), TANK-binding kinase 1 (TBK1), and interferon regulatory factor 3 (IRF3). The subsequent type I and III IFN responses result in preferential induction of peripheral ISG responses. Following this initial innate immune activation, peripheral expression of the HIV-1 restriction factor SAM domain- and HD domain-containing protein 1 (SAMHD1) returns to levels below those observed in uninfected mice, suggesting that HIV-1 interferes with their basal expression. However, peripheral cells still retain their responsiveness to exogenous type I IFN, whereas splenic cells show a reduction in select ISGs in response to IFN. This demonstrates the highly dynamic nature of very early HIV-1 infection and suggests that blocks to the induction of HIV-1 restriction factors contribute to the establishment of viral persistence.

Indexed as

AnimalsCD4-Positive T-LymphocytesDendritic CellsHEK293 CellsHIV-1HIV InfectionsHumansImmunity, InnateInterferon Regulatory Factor-3Interferon Type IKineticsMacrophagesMiceNF-kappa BProtein Serine-Threonine KinasesSAM Domain and HD Domain-Containing Protein 1Interferon Regulatory Factor-3Interferon Type IIRF3 protein, humanNF-kappa BProtein Serine-Threonine KinasesSAM Domain and HD Domain-Containing Protein 1SAMHD1 protein, humanTBK1 protein, humanhuman immunodeficiency virushumanized mouseinnate immunity

Identifiers

PMID30867315
PMCPMC6532090
OpenAlexW2921822809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.